by Talking Medicines | Sep 8, 2021
How do you translate patient-centered ambition into reality? #dothingsdifferently The answer is, listen to your patients, how you do that can be the tricky bit. For a long time (I’ve been in the pharma industry for 20+ years) I’ve heard of the...
by Talking Medicines | Sep 3, 2021
What is Sentiment Analysis? Sentiment analysis can also be referred to as ‘opinion mining’ which is a natural language processing technique used to determine whether data is positive, negative or neutral. Monkeylearn, 2021 Sentiment analysis is often...
by Talking Medicines | Aug 27, 2021
Bankmycell, 2021 It is important we remember that patients are people… 48.2% of our worldwide population own a smartphone. Roughly 3.46 billion people out of this 3.80 billion use mobile devices for social media. This means that people are actively...
by Talking Medicines | Aug 20, 2021
The Value of AI According to one article, ‘Masters in Data Analytics’ written by Maryville university, “The world was entrenched in big data before it even realised that big data existed. By the time the term was coined, big data had accumulated a...
by Talking Medicines | Aug 12, 2021
Overview At Talking Medicines, we understand how regulated the pharmaceutical industry is, and understand that within the industry there are many unclear areas around Artificial Intelligence (AI). We are closely following the guidance around this from regulators,...
by Talking Medicines | Aug 6, 2021
Marketing Excellence encompasses the actual delivery of promised benefits to the end-user. For the Pharma sector, regulation has largely prevented direct conversation with patients, and to some extent, the sector has been unable to take advantage of the...